• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人铁螯合酶的沉默导致结肠癌中大量原卟啉-IX积累。

Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.

作者信息

Kemmner Wolfgang, Wan Kayiu, Rüttinger Steffen, Ebert Bernd, Macdonald Rainer, Klamm Ursula, Moesta K Thomas

机构信息

Max Delbrueck Center for Molecular Medicine, Robert Roessle Str 10, 13125 Berlin, Germany.

出版信息

FASEB J. 2008 Feb;22(2):500-9. doi: 10.1096/fj.07-8888com. Epub 2007 Sep 17.

DOI:10.1096/fj.07-8888com
PMID:17875605
Abstract

Hemes and heme proteins are vital components of essentially every cell of virtually every eukaryote organism. Previously, we demonstrated accumulation of the heme precursor protoporphyrin-IX (PpIX) in gastrointestinal tumor tissues. To elucidate the mechanisms of PpIX accumulation by quantitative reverse transcriptase-polymerase chain reaction (RT-PCR), we studied expression of the relevant enzymes of the heme synthetic pathway. Here, we describe a significant down-regulation of ferrochelatase (FECH) mRNA expression in gastric, colonic, and rectal carcinomas. Accordingly, in an in vitro model of several carcinoma cell lines, ferrochelatase down-regulation and loss of enzymatic activity corresponded with an enhanced PpIX-dependent fluorescence. Direct detection of PpIX in minute amounts was achieved by a specifically developed pulsed solid-state laser dual delay fluorimetry setup. Silencing of FECH using small interfering RNA (siRNA) technology led to a maximum 50-fold increased PpIX accumulation, imageable by a specifically adapted two-photon microscopy unit. Our results show that in malignant tissue a transcriptional down-regulation of FECH occurs, which causes endogenous PpIX accumulation. Furthermore, accumulation of intracellular PpIX because of FECH siRNA silencing provides a small-molecule-based approach to molecular imaging and molecular therapy.

摘要

血红素和血红素蛋白几乎是每一种真核生物的每个细胞的重要组成部分。此前,我们证明了血红素前体原卟啉-IX(PpIX)在胃肠道肿瘤组织中的积累。为了通过定量逆转录聚合酶链反应(RT-PCR)阐明PpIX积累的机制,我们研究了血红素合成途径相关酶的表达。在此,我们描述了胃癌、结肠癌和直肠癌中铁螯合酶(FECH)mRNA表达的显著下调。相应地,在几种癌细胞系的体外模型中,铁螯合酶的下调和酶活性的丧失与增强的PpIX依赖性荧光相对应。通过专门开发的脉冲固态激光双延迟荧光测定装置实现了对微量PpIX的直接检测。使用小干扰RNA(siRNA)技术沉默FECH导致PpIX积累最多增加50倍,可通过专门改装的双光子显微镜单元成像。我们的结果表明,在恶性组织中发生了FECH的转录下调,这导致内源性PpIX积累。此外,由于FECH siRNA沉默导致的细胞内PpIX积累为分子成像和分子治疗提供了一种基于小分子的方法。

相似文献

1
Silencing of human ferrochelatase causes abundant protoporphyrin-IX accumulation in colon cancer.人铁螯合酶的沉默导致结肠癌中大量原卟啉-IX积累。
FASEB J. 2008 Feb;22(2):500-9. doi: 10.1096/fj.07-8888com. Epub 2007 Sep 17.
2
Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.靶向致癌性 Ras/MEK 通路增强癌症特异性原卟啉 IX 荧光。
Theranostics. 2018 Mar 8;8(8):2134-2146. doi: 10.7150/thno.22641. eCollection 2018.
3
Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.亚铁螯合酶沉默增强基于 5-氨基酮戊酸的荧光和光动力治疗效果。
Br J Cancer. 2011 Mar 1;104(5):798-807. doi: 10.1038/bjc.2011.12. Epub 2011 Feb 8.
4
Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.亚铁螯合酶缺乏症可消除铁螯合剂去铁胺对氨基酮戊酸介导的原卟啉 IX 的增强作用。
Photochem Photobiol. 2019 Jul;95(4):1052-1059. doi: 10.1111/php.13091. Epub 2019 Mar 15.
5
Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.沉默血红素生物合成酶对5-氨基酮戊酸介导的原卟啉IX荧光及光动力疗法的影响
Photochem Photobiol. 2015 Jul-Aug;91(4):923-30. doi: 10.1111/php.12454. Epub 2015 Apr 8.
6
Accumulation of protoporphyrin IX in medulloblastoma cell lines and sensitivity to subsequent photodynamic treatment.原卟啉 IX 在髓母细胞瘤细胞系中的积累及其对随后光动力治疗的敏感性。
J Photochem Photobiol B. 2018 Dec;189:298-305. doi: 10.1016/j.jphotobiol.2018.11.002. Epub 2018 Nov 7.
7
Methods to Measure the Inhibition of ABCG2 Transporter and Ferrochelatase Activity to Enhance Aminolevulinic Acid-Protoporphyrin IX Fluorescence-Guided Tumor Detection and Resection.测量 ABCG2 转运蛋白和亚铁螯合酶活性抑制的方法,以增强氨基酮戊酸-原卟啉 IX 荧光引导的肿瘤检测和切除。
Methods Mol Biol. 2022;2394:823-835. doi: 10.1007/978-1-0716-1811-0_43.
8
Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA.铁螯合酶变异体mRNA对其表达的转录后调控。
J Biochem. 2009 Jun;145(6):733-8. doi: 10.1093/jb/mvp030. Epub 2009 Feb 27.
9
Kinetic Evaluation of Determinant Factors for Cellular Accumulation of Protoporphyrin IX Induced by External 5-Aminolevulinic Acid for Photodynamic Cancer Therapy.用于光动力癌症治疗的外源性5-氨基乙酰丙酸诱导细胞内原卟啉IX蓄积的决定因素的动力学评估
J Pharm Sci. 2015 Sep;104(9):3092-100. doi: 10.1002/jps.24462. Epub 2015 May 8.
10
Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.调控 5-氨基酮戊酸介导的原卟啉 IX 在人尿路上皮癌中的积累。
Pathobiology. 2009;76(6):303-14. doi: 10.1159/000245896. Epub 2009 Nov 30.

引用本文的文献

1
A PPIX-binding probe facilitates discovery of PPIX-induced cell death modulation by peroxiredoxin.一种与 PPi 结合的探针促进了过氧化物酶的发现,该酶可调节 PPi 诱导的细胞死亡。
Commun Biol. 2023 Jun 24;6(1):673. doi: 10.1038/s42003-023-05024-5.
2
5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy.5-氨基酮戊酸作为肿瘤荧光成像和光动力治疗的诊疗试剂
Bioengineering (Basel). 2023 Apr 21;10(4):496. doi: 10.3390/bioengineering10040496.
3
Active site architecture of coproporphyrin ferrochelatase with its physiological substrate coproporphyrin III: Propionate interactions and porphyrin core deformation.
与生理底物粪卟啉 III 共有的原卟啉原IX 亚铁螯合酶的活性部位结构:丙酸盐相互作用和卟啉核心变形。
Protein Sci. 2023 Jan;32(1):e4534. doi: 10.1002/pro.4534.
4
C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.肿瘤间质干细胞样细胞分泌的 C5α 介导电动力学疗法抵抗基于 5-氨基酮戊酸的胶质母细胞瘤肿瘤球治疗。
J Cancer Res Clin Oncol. 2023 Jul;149(8):4391-4402. doi: 10.1007/s00432-022-04347-w. Epub 2022 Sep 15.
5
FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma.FECH表达与透明细胞肾细胞癌的预后及肿瘤免疫微环境相关。
J Oncol. 2022 Aug 25;2022:8943643. doi: 10.1155/2022/8943643. eCollection 2022.
6
Evolutionary Trend Analysis of Research on 5-ALA Delivery and Theranostic Applications Based on a Scientometrics Study.基于科学计量学研究的5-氨基乙酰丙酸递送及诊疗应用研究的进化趋势分析
Pharmaceutics. 2022 Jul 15;14(7):1477. doi: 10.3390/pharmaceutics14071477.
7
Small-molecule inhibitors of ferrochelatase are antiangiogenic agents.亚铁螯合酶的小分子抑制剂是血管生成抑制剂。
Cell Chem Biol. 2022 Jun 16;29(6):1010-1023.e14. doi: 10.1016/j.chembiol.2022.01.001. Epub 2022 Jan 31.
8
Analysis of Factors Affecting 5-ALA Fluorescence Intensity in Visualizing Glial Tumor Cells-Literature Review.分析影响 5-ALA 荧光强度显示神经胶质细胞瘤细胞因素的文献综述。
Int J Mol Sci. 2022 Jan 15;23(2):926. doi: 10.3390/ijms23020926.
9
Down-regulation of IGHG1 enhances Protoporphyrin IX accumulation and inhibits hemin biosynthesis in colorectal cancer by suppressing the MEK-FECH axis.IGHG1的下调通过抑制MEK-FECH轴增强了原卟啉IX的积累并抑制了结直肠癌中的血红素生物合成。
Open Life Sci. 2021 Sep 6;16(1):930-936. doi: 10.1515/biol-2021-0098. eCollection 2021.
10
Small molecule kinase inhibitors enhance aminolevulinic acid-mediated protoporphyrin IX fluorescence and PDT response in triple negative breast cancer cell lines.小分子激酶抑制剂增强三阴性乳腺癌细胞系中氨基酮戊酸介导的原卟啉 IX 荧光和 PDT 反应。
J Biomed Opt. 2021 Sep;26(9). doi: 10.1117/1.JBO.26.9.098002.